311 related articles for article (PubMed ID: 28027731)
21. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis.
El-Sherif A; Gooding WE; Santos R; Pettiford B; Ferson PF; Fernando HC; Urda SJ; Luketich JD; Landreneau RJ
Ann Thorac Surg; 2006 Aug; 82(2):408-15; discussion 415-6. PubMed ID: 16863738
[TBL] [Abstract][Full Text] [Related]
22. Prognostic predictors in non-small cell lung cancer patients undergoing intentional segmentectomy.
Koike T; Koike T; Yamato Y; Yoshiya K; Toyabe S
Ann Thorac Surg; 2012 Jun; 93(6):1788-94. PubMed ID: 22560265
[TBL] [Abstract][Full Text] [Related]
23. The side of pneumonectomy influences long-term survival in stage I and II non-small cell lung cancer.
Simón C; Moreno N; Peñalver R; González G; Alvarez-Fernández E; González-Aragoneses F;
Ann Thorac Surg; 2007 Sep; 84(3):952-8. PubMed ID: 17720406
[TBL] [Abstract][Full Text] [Related]
24. [Analysis of prognostic factors in 1826 patients with completely resected non-small cell lung cancer].
Gao YS; Xing XZ; Shao K; Feng XL; He J
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):134-7. PubMed ID: 18646698
[TBL] [Abstract][Full Text] [Related]
25. Induction therapy followed by surgery for T3-T4/N0 non-small cell lung cancer: long-term results.
Lococo F; Cesario A; Margaritora S; Dall'Armi V; Nachira D; Cusumano G; Meacci E; Granone P
Ann Thorac Surg; 2012 May; 93(5):1633-40. PubMed ID: 22480394
[TBL] [Abstract][Full Text] [Related]
26. Characteristics and Clinical Outcomes of Sarcomatoid Carcinoma of the Lung.
Ung M; Rouquette I; Filleron T; Taillandy K; Brouchet L; Bennouna J; Delord JP; Milia J; Mazières J
Clin Lung Cancer; 2016 Sep; 17(5):391-397. PubMed ID: 27105684
[TBL] [Abstract][Full Text] [Related]
27. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
[TBL] [Abstract][Full Text] [Related]
28. Surgical treatment of metachronous second primary lung cancer after complete resection of non-small cell lung cancer.
Hamaji M; Allen MS; Cassivi SD; Deschamps C; Nichols FC; Wigle DA; Shen KR
J Thorac Cardiovasc Surg; 2013 Mar; 145(3):683-90; discussion 690-1. PubMed ID: 23414986
[TBL] [Abstract][Full Text] [Related]
29. Surgical treatment of metachronous second primary lung cancer.
Yang J; Liu M; Fan J; Song N; He WX; Yang YL; Xia Y; Jiang GN
Ann Thorac Surg; 2014 Oct; 98(4):1192-8. PubMed ID: 25134862
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary Sarcomatoid Carcinoma: An Analysis of the National Cancer Data Base.
Steuer CE; Behera M; Liu Y; Fu C; Gillespie TW; Saba NF; Shin DM; Pillai RN; Pakkala S; Owonikoko TK; Khuri FR; Ramalingam SS
Clin Lung Cancer; 2017 May; 18(3):286-292. PubMed ID: 28043773
[TBL] [Abstract][Full Text] [Related]
31. Long-term results of combined-modality therapy in resectable non-small-cell lung cancer.
Martin J; Ginsberg RJ; Venkatraman ES; Bains MS; Downey RJ; Korst RJ; Kris MG; Rusch VW
J Clin Oncol; 2002 Apr; 20(8):1989-95. PubMed ID: 11956257
[TBL] [Abstract][Full Text] [Related]
32. Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections.
Sienel W; Dango S; Kirschbaum A; Cucuruz B; Hörth W; Stremmel C; Passlick B
Eur J Cardiothorac Surg; 2008 Apr; 33(4):728-34. PubMed ID: 18261918
[TBL] [Abstract][Full Text] [Related]
33. Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
J Thorac Cardiovasc Surg; 2005 Jan; 129(1):87-93. PubMed ID: 15632829
[TBL] [Abstract][Full Text] [Related]
34. Does bilobectomy offer satisfactory long-term survival outcome for non-small cell lung cancer?
Icard P; Heyndrickx M; Galateau-Sallé F; Rosat P; Lerochais JP; Gervais R; Zalcman G; Hanouz JL
Ann Thorac Surg; 2013 May; 95(5):1726-33. PubMed ID: 23561806
[TBL] [Abstract][Full Text] [Related]
35. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.
Hsu CP; Hsia JY; Chang GC; Chuang CY; Shai SE; Yang SS; Lee MC; Kwan PC
J Thorac Cardiovasc Surg; 2009 Aug; 138(2):426-33. PubMed ID: 19619791
[TBL] [Abstract][Full Text] [Related]
36. Predictors of recurrence and disease-free survival in patients with completely resected esophageal carcinoma.
Lee PC; Mirza FM; Port JL; Stiles BM; Paul S; Christos P; Altorki NK
J Thorac Cardiovasc Surg; 2011 May; 141(5):1196-206. PubMed ID: 21397267
[TBL] [Abstract][Full Text] [Related]
37. Surgical Therapy for Bilateral Multiple Primary Lung Cancer.
Yang H; Sun Y; Yao F; Yu K; Gu H; Han B; Zhao H
Ann Thorac Surg; 2016 Mar; 101(3):1145-52. PubMed ID: 26602007
[TBL] [Abstract][Full Text] [Related]
38. Intratumoral lymphatic vessel involvement is an invasive indicator of completely resected pathologic stage I non-small cell lung cancer.
Harada M; Hato T; Horio H
J Thorac Oncol; 2011 Jan; 6(1):48-54. PubMed ID: 21079523
[TBL] [Abstract][Full Text] [Related]
39. Preoperative quality of life predicts survival following pulmonary resection in stage I non-small-cell lung cancer.
Pompili C; Salati M; Refai M; Berardi R; Onofri A; Mazzanti P; Brunelli A
Eur J Cardiothorac Surg; 2013 May; 43(5):905-10. PubMed ID: 23091229
[TBL] [Abstract][Full Text] [Related]
40. [Multivariate survival analysis of 899 patients with non-small cell lung cancer after complete resection].
Wei WD; Wen ZS; Su XD; Lin P; Rong TH; Chen LK
Ai Zheng; 2007 Nov; 26(11):1231-6. PubMed ID: 17991324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
